NEW YORK (GenomeWeb) – Bionano Genomics has filed for an initial public offering in which it plans to raise up to $34.5 million.

According to a preliminary prospectus filed with the US Securities and Exchange Commission yesterday, the San Diego-based company plans to offer a yet to be determined number of shares of its common stock for a maximum aggregate offering price of $34.5 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.